1 / 4

Anti-Hypertensive Drugs Market

Anti-Hypertensive Drugs Market

farazp70
Download Presentation

Anti-Hypertensive Drugs Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research Anti-Hypertensive Drugs Market Size, Share, Growth, Industry Analysis Report and Forecast to 2025 Request https://www.omrglobal.com/request-sample/antidepressant-drugs-market a free sample of our report on Market: Anti-Hypertensive Drugs ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The global anti-hypertension drugs market is estimated to grow at a CAGR of over 4% during the forecast period. Hypertension is a common condition among patients with diabetes. Hence, the adoption of anti-hypertensive is high among the diabetic population for the treatment of hypertension. Hence, the increased diabetic population coupled with the adoption of anti- hypertensive drugs is anticipated to drive the anti-hypertensive drug market industry significantly. Additionally, Angiotensin-converting enzyme (ACE) inhibitors manufactured by companies such as Novartis AG and Pfizer Inc. are the most used anti-hypertensive drugs by diabetic patients. Get Sample Copy of Anti-Hypertensive Drugs Market at: https://www.omrglobal.com/request-sample/anti-hypertensive-drugs-market Some of thekey players operating in the global anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi SA, Boehringer Ingelheim International GmbH, AstraZeneca PLC, Daiichi Sankyo Co.Ltd., Teva Pharmaceutical Industries Ltd., and others. Furthermore, hypertension is a major risk factor for patients suffering from conditions such as atherosclerotic cardiovascular disease (ASCVD), heart failure, and microvascular complications. ASCVD is considered to be a leading cause of morbidity and mortality in patients with diabetes. In recent years, numerous studies have shown that anti-hypertensive drug therapy can aid in significantly reducing ASCVD events. Along with ASCVD, anti-hypertensive drugs can aid in conditions such as heart failure, and microvascular complications in diabetic patients. Hence, the positive effects of anti-hypertensive drugs on ASCVD and other conditions are anticipated to drive the anti-hypertensive drugs market growth considerably during the forecast period. For More Information, get A full report of Anti-Hypertensive Drugs Market is available at: https://www.omrglobal.com/press-release/global-anti-hypertensive-drugs-market Additionally, anti-hypertensive drug-based treatment can be given to the patient either as monotherapy or in suitable combinations. In addition to this, anti-hypertensive drugs also show good outcomes when used for non-pharmacological treatment such as low salt diet, weight loss, exercise, in diabetic patients which impact the anti-hypertensive drug market. Moreover, various government organizations across the globe are involved in the study of hypertension in diabetic patients that have also suggested the use of anti-hypertensive drugs in their guidelines, which in turn, is expected to expand the anti-hypertensive drug market size. For instance, in the guidelines from European Society of Hypertension (ESH) and European Society of Cardiology, the use of drugs such as thiazide diuretics, ?-blockers, calcium channel blockers (CCBs), ACEis and angiotensin II receptor blockers (ARBs) are recommended for the initiation and maintenance of hypertension in diabetic patients. The drugs recommended in

  3. guidelines are anti-hypertensive drugs that are preferred to be used mostly in diabetic patients. Therefore, the guidelines from ESH and European Society of Cardiology, regarding the use of anti-hypertensive drugs are expected to drive the anti-hypertensive drugs market growth significantly during the forecasted period. Anti-Hypertensive Drugs Market- Segmentation By Drug Class •Thiazide Diuretics •Calcium Channel Blockers •ACE Inhibitors •Angiotensin II Receptor Antagonists (ARBS) •Beta-Blockers •Others Anti-Hypertensive Drugs Market- Segment by Region North America •US •Canada Europe •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World •Latin America •Middle East Africa

  4. For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/anti-hypertensive-drugs-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

More Related